News
This dose-ranging study used the acute febrile sore throat model (oral temperature ≥38.0°C) to establish the lowest reliable antipyretic and analgesic dose of diclofenac potassium (6.25, 12.5 ...
Objective: To compare the antipyretic and analgesic effects of a single oral dose of diclofenac potassium 6.25, 12.5 or 25mg with paracetamol 1000mg and placebo in patients with fever resulting ...
On May 6, 2025, the Global Initiative For Asthma (GINA) published the 2025 update to their Global Strategy for Asthma Management and Prevention guidance report. Chair of the GINA Dissemination Working ...
Oxford researchers have developed programmable microcapsules to deliver vaccines in stages, potentially eliminating the need ...
Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...
Introduction There are persistent gaps in access to affordable medicines. The WHO Model List of Essential Medicines (EML) includes medicines considered necessary for functional health systems.Methods ...
The FDA has approved Widaplik (telmisartan, amlodipine and indapamide) for the treatment of hypertension, including as initial treatment, to lower blood pressure.
Medicine Buddy ™ — Medicine Dispensers with removable pacifier attachment allows for precise and fuss-free medication delivery; suitable for all ages 0M+. Riley the Rocket or Bella the ...
SYMBRAVO (meloxicam and rizatriptan, 20 mg/10mg tablets) is a novel, oral, single-dose medicine approved for the acute treatment of migraine with or without aura in adults. SYMBRAVO consists of ...
SYMBRAVO (meloxicam and rizatriptan, 20 mg/10mg tablets) is a novel, oral, single-dose medicine approved for the acute treatment of migraine with or without aura in adults. SYMBRAVO consists of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results